How Continuous Glucose Monitors Became a Wellness Gadget for Healthy People

A small white disc on the back of someone’s arm used to signal one thing: they had diabetes. Today, that same device is just as likely to be worn by a personal trainer, a tech entrepreneur, or a university student who saw it on TikTok. Continuous glucose monitors — CGMs — have crossed the boundary from medical device to consumer wellness gadget, and the shift happened faster than most health professionals expected.

The first CGM was cleared by the FDA in 1999, exclusively for diabetes management. In March 2024, the FDA cleared the first over-the-counter model, the Dexcom Stelo, for adults not on insulin. That single regulatory decision opened the floodgates. Companies like Levels, Nutrisense, Signos, and Abbott’s Lingo now market directly to healthy consumers, promising insights into how food, exercise, stress, and sleep affect blood sugar — and, by extension, everything from energy levels to body composition to long-term disease risk.

What CGMs Actually Do

A CGM is a wearable sensor, typically applied to the upper arm or abdomen, that measures interstitial glucose levels every one to five minutes and sends the data to a smartphone app. Unlike a traditional finger-prick test that gives a single snapshot, a CGM produces a continuous stream — showing not just where your glucose is, but where it’s heading and how quickly it got there.

For people with diabetes, particularly those on insulin, this data is genuinely life-saving. It enables precise dosing, prevents dangerous hypoglycaemic episodes, and has been shown to improve HbA1c levels. The clinical case is settled.

For healthy people, the picture is murkier. The appeal is intuitive — who wouldn’t want a real-time window into their body’s metabolic response? But as Johns Hopkins epidemiologist Elizabeth Selvin noted in January 2026, the clinical frameworks for interpreting CGM data were built for diabetics. What constitutes a “normal” glucose spike after a meal in a healthy person, what range is optimal, and whether manipulating those patterns actually improves outcomes — these questions remain largely unanswered.

The Wellness Case vs. the Evidence

The marketing pitch is compelling: wear a CGM, learn which foods spike your blood sugar, and optimise your diet for energy, weight loss, and disease prevention. The reality is more nuanced.

Claim	What research supports	What research doesn’t support
CGMs reveal how food affects blood sugar	Yes — individual postprandial responses vary significantly, and CGMs capture this in real time	That this information leads to measurably better health outcomes in non-diabetics
CGMs help with weight loss	Some users report a behaviour change from seeing spike data	No controlled trials show CGM-driven weight loss in healthy populations
CGMs detect early metabolic dysfunction	Emerging research shows CGM patterns can distinguish normal from impaired glucose tolerance with ~91% accuracy	That routine CGM use is more effective than standard lab screening (HbA1c, fasting glucose)
CGMs improve athletic performance	Data on exercise timing relative to glucose peaks shows promise	Limited evidence in healthy recreational athletes; most studies focus on elite populations
CGMs prevent diabetes	Plausible in theory — better dietary choices reduce risk	No long-term studies confirm this causal pathway through CGM use specifically

A 2025 systematic review in Cureus examining CGM use in non-diabetic populations for cardiovascular prevention found that while the technology can guide lifestyle interventions, the evidence base remains small and the clinical significance uncertain. The review noted that most studies lacked control groups and relied on short observation periods.

The Data Obsession Problem

Here’s where CGMs for healthy people get genuinely complicated. The same features that make the devices useful for diabetics — constant real-time feedback, alerts, trend arrows — can become psychologically problematic when applied to people whose glucose is already functioning normally.

Healthy glucose fluctuates throughout the day. A spike after a banana doesn’t mean the banana is “bad.” A dip in the afternoon doesn’t necessarily indicate anything actionable. But when you can see every fluctuation on your phone, the temptation to optimise, restrict, and control becomes significant. Health professionals have flagged the risk of CGMs fuelling orthorexia — an obsessive preoccupation with “healthy” eating — particularly in younger users who are already navigating complex relationships with food and body image.

The parallel to other forms of data tracking is worth noting. We live in an era where quantifying personal behaviour has become a default leisure activity — tracking steps, sleep cycles, screen time, and even entertainment habits. Whether you’re reviewing your weekly step count, checking how long you spent on an app, or browsing the latest promotions at Spin City casino NZ during a quiet evening, the underlying impulse is the same: the belief that more data equals more control. CGMs tap into this impulse more powerfully than most wearables because the data feels medically significant, even when it may not be.

Who Should Actually Consider One

Not everyone who’s curious about CGMs should avoid them. There are scenarios where the data genuinely helps:

• People with prediabetes or a family history of type 2 diabetes stand to benefit most, as CGM data can reveal patterns that standard tests miss and motivate dietary changes before clinical thresholds are crossed.
• Athletes training at high intensity can use glucose data to refine fuelling strategies around workouts, though the evidence is strongest for endurance sports.
• Anyone working with a qualified dietitian or metabolic health professional who can interpret the data in context, rather than relying on app-generated scores or social media advice.
• Short-term exploratory use — wearing a CGM for two to four weeks to learn personal glucose responses, then applying that knowledge without ongoing monitoring — is increasingly recommended as a balanced approach.

For the average healthy person without specific risk factors, the value proposition is less clear. Standard lab tests, a balanced diet, regular movement, and adequate sleep will do more for long-term metabolic health than any wearable can.

The Bigger Picture

CGMs represent a broader tension in modern wellness: the gap between what technology can measure and what those measurements actually mean. The devices work brilliantly. The sensors are accurate. The apps are polished. But the clinical infrastructure for translating that data into actionable, evidence-based guidance for healthy people hasn’t caught up yet. Until it does, the risk is that CGMs become another source of wellness anxiety rather than genuine health improvement — a sophisticated gadget answering a question that, for most people, didn’t need asking.

About Author